$5.08
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
Nu Skin Enterprises, Inc. in the Consumer Defensive sector is trading at $5.08 with a market capitalization of $248M. The stock is currently near its 52-week low of $4.89, remaining 37.6% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $320.61Mβ | $370.32Mβ | $364.21Mβ | $386.14Mβ | $364.49M |
| Gross Profit | $214.46Mβ | $261.98Mβ | $256.72Mβ | $265.73Mβ | $246.96M |
| Operating Income | $5.87Mβ | $23.24Mβ | $21.64Mβ | $30.78Mβ | $15.21M |
| Net Income | $1.84Mβ | $14.49Mβ | $17.08Mβ | $21.12Mβ | $107.52M |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiS...
EL, ULTA and ELF capitalize on premiumization, product innovation and digital engagement as the beauty and cosmetics industry continues to evolve.
e.l.f. Beauty targets double-digit fiscal 2027 sales growth, but sustaining the run hinges on Rhode's scale and stronger core brand momentum.
Caleres, GIII Apparel, Nu Skin, Apple Hospitality and Green Dot make Zacks' list of undervalued stocks with attractive price-to-sales ratios.
EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies for 2H 2026.
Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.